Vardenafil dihydrochloride

This classification denotes the dihydrochloride form of a cgmp phosphodiesterase inhibitor with the molecular formula C23H32N6O4S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier UCE6F4125H, chemically known as 2-(2-ethoxy-5-(4-ethylpiperazin-1-yl-1-sulfonyl)phenyl)-5-methyl-7-propyl-3h-imidazo(5,1-f)(1,2,4)triazin-4-one but more generally known as vardenafil, which bears US NIH Compound Identifier 110634. European Medicines Agency schedules Vardenafil in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB20047. The term VARDENAFIL is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 14, No. 3, 2000, List 44). World Health Organization schedules vardenafil in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations, for tariff and trade purposes, schedule vardenafil dihydrochloride under HS 29350090 and SITC 51580. As of Q4 2014, VARDENAFIL DIHYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Vardenafil dihydrochloride bears US NLM identifiers UMLS ID C2700155 and NCI Concept Code C76892. SMILES: CCCC1NC(C2N1NC([NH]C2=O)C3CC(CCC3OCC)S(=O)(=O)N4CCN(CC4)CC)C.CL.CL.